Welcome to the new ebulletin for the Faculty For information published before 29 April 2014, please see the old ebulletin New submissions can be sent to email@example.com
Wednesday, 3 December 2014
World-first aspirin study reaches new milestone
Australia’s largest clinical trial is a step closer to revealing in 2018 whether healthy older people should or should not take aspirin to prevent or delay cardiovascular disease (heart attack and stroke), dementia, depression and some types of cancers. ASPREE (ASPirin in Reducing Events in the Elderly), a randomised, placebo controlled trial in older people, today reached its recruitment target of 19,000 participants in Australia and the US.
Led by Monash University and the Berman Center for Outcomes and Clinical Research in the US, the ASPREE trial will measure extended years of living free from physical and cognitive disability, to determine the benefits versus the risks of daily low-dose aspirin.